Fatal early graft failure in a heart transplant recipient with occult multivessel coronary artery disease in a young donor: implications for donor evaluation Authors: Gutenberg Navarro-Zambrano, Humberto Martínez-Hernández, Mauricio Soulé-Egea, Alberto Aranda-Fraustro, Rommel Espinoza de los Monteros-Duche, Carlos Latorre-Dávila, Isabel Echevarría-Frutos, Amaury León-Sosa, Juan Pérez-Reyes Published: 2026 ABSTRACT BackgroundPrimary graft dysfunction (PGD) represents the leading cause of early mortality following heart transplantation. Among the associated factors, donor characteristics—particularly the presence of undiagnosed coronary artery disease—may play a relevant role. Donor evaluation is typically based on clinical assessment and echocardiographic findings, which may be insufficient to detect subclinical coronary disease, especially in young donors.Case presentationWe report the case of a 52-year-old patient with advanced dilated cardiomyopathy who underwent orthotopic heart transplantation. The donor was a 27-year-old male with no known medical history, evaluated at a secondary-level hospital using electrocardiography and transthoracic echocardiography, both without pathological findings. Following transplantation, the recipient developed severe hemodynamic instability progressing to primary graft dysfunction. Initially, hyperacute rejection was considered in the differential diagnosis given the early and severe graft dysfunction. A postoperative electrocardiogram reportedly showed no ischemic changes; however, a marked elevation in troponin I (80 ng/mL) was documented, suggesting significant myocardial injury. A transesophageal echocardiogram demonstrated global biventricular systolic dysfunction. Mechanical circulatory support with venoarterial extracorporeal membrane oxygenation and intra-aortic balloon pump was required. Despite intensive management, the patient developed multiorgan failure and died within the first 24 h postoperatively. Postmortem histopathological examination of the graft revealed severe multivessel atherosclerotic coronary artery disease that had not been previously diagnosed.ConclusionThis case suggests a possible association between undiagnosed donor coronary artery disease and early graft failure, while highlighting the limitations of conventional donor evaluation, particularly in detecting non-calcified coronary lesions. These findings underscore the need for cautious interpretation of donor assessment, especially in resource-limited settings.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s13019-026-04356-7. Introduction Heart transplantation remains the treatment of choice for advanced heart failure; however, early postoperative mortality continues to be significant, with primary graft dysfunction (PGD) representing its leading cause [1]. PGD is defined as severe graft dysfunction occurring within the first 24 h after transplantation in the absence of identifiable secondary causes, and it is associated with high early mortality [2, 3]. Among the contributing factors, donor characteristics may play a relevant role, particularly the presence of undiagnosed coronary artery disease [4, 5]. Donor evaluation is typically based on clinical history, electrocardiography, and transthoracic echocardiography; however, these tools may be insufficient to detect subclinical atherosclerotic coronary artery disease. This limitation is especially relevant in young donors, in whom the absence of traditional cardiovascular risk factors is often assumed to indicate low risk, potentially leading to underestimation of significant coronary pathology [6]. We report the case of a patient who underwent orthotopic heart transplantation and developed fatal primary graft dysfunction in the context of previously undiagnosed multivessel atherosclerotic coronary artery disease in a young donor, highlighting important implications for current donor screening strategies. Case presentation A 52-year-old man with a history of advanced familial dilated cardiomyopathy, complete atrioventricular block, and an implanted cardiac resynchronization therapy defibrillator (CRT-D, Medtronic), as well as type 2 diabetes mellitus, multinodular goiter, and permanent atrial fibrillation, presented with progressive heart failure. His clinical course was characterized by severe left ventricular systolic dysfunction (ejection fraction 20%) and recurrent ventricular arrhythmias. Transthoracic echocardiography demonstrated severe dilation of all cardiac chambers, eccentric left ventricular hypertrophy, and severe systolic dysfunction (Fig. 1). The patient was listed for heart transplantation through the National Transplant Center of Mexico (CENATRA). Fig. 1Preoperative assessment of the recipient. (A) Chest X-ray showing severe cardiomegaly and bilateral pleural effusions. (B) Coronary cineangiography without evidence of coronary lesions. (C) Transthoracic echocardiography (TTE) demonstrating severe dilation of all cardiac chambers and global left ventricular systolic dysfunction, with an estimated ejection fraction of 20%, consistent with advanced dilated cardiomyopathy Preoperative assessment of the recipient. (A) Chest X-ray showing severe cardiomegaly and bilateral pleural effusions. (B) Coronary cineangiography without evidence of coronary lesions. (C) Transthoracic echocardiography (TTE) demonstrating severe dilation of all cardiac chambers and global left ventricular systolic dysfunction, with an estimated ejection fraction of 20%, consistent with advanced dilated cardiomyopathy A donor organ became available from a 27-year-old male with no known medical history who suffered severe traumatic brain injury following a motorcycle accident. Brain death was confirmed 24 h after hospital admission, and he was accepted for organ donation. The donor had a body mass index of 27 kg/m². Information regarding smoking history was not available in the referring institution records. The donor was hemodynamically stable without the need for inotropic or vasopressor support. Donor evaluation, performed at a secondary-level hospital, included laboratory testing, electrocardiography, and transthoracic echocardiography, without access to invasive coronary assessment. Laboratory results were within normal limits (Table 1). Table 1Laboratory parameters of the cardiac donor at the time of evaluationParameterValueReference rangeLeukocytes (×10⁹/L)7.84.0–10.0Neutrophils (%)6240–70Hemoglobin (g/dL)14.513.5–17.5Hematocrit (%)4341–53Lymphocytes (%)3020–40Platelets (×10⁹/L)245150–400Triglycerides (mg/dL)110< 150LDL Cholesterol (mg/dL)95< 100HDL Cholesterol (mg/dL)52> 40AST (Aspartate Aminotransferase) (U/L)2810–40ALT (Alanine Aminotransferase) (U/L)317–56Creatinine (mg/dL)10.7–1.3Urea (mg/dL)1815–40Glucose (mg/dL)8970–100Prothrombin Time (s)12.111–13.5INR10.8–1.2aPTT (s)2925–35Troponin I (ng/mL)0.01< 0.04CK (Creatine Kinase) (U/L)10530–200CK-MB (ng/mL)2.3< 5NT-proBNP (pg/mL)85< 125Serologic Screening for HIV, HBV, HCV, Trypanosoma cruzi (Chagas disease), and SyphilisNegativeNegative Table 1Laboratory parameters of the cardiac donor at the time of evaluationParameterValueReference rangeLeukocytes (×10⁹/L)7.84.0–10.0Neutrophils (%)6240–70Hemoglobin (g/dL)14.513.5–17.5Hematocrit (%)4341–53Lymphocytes (%)3020–40Platelets (×10⁹/L)245150–400Triglycerides (mg/dL)110< 150LDL Cholesterol (mg/dL)95< 100HDL Cholesterol (mg/dL)52> 40AST (Aspartate Aminotransferase) (U/L)2810–40ALT (Alanine Aminotransferase) (U/L)317–56Creatinine (mg/dL)10.7–1.3Urea (mg/dL)1815–40Glucose (mg/dL)8970–100Prothrombin Time (s)12.111–13.5INR10.8–1.2aPTT (s)2925–35Troponin I (ng/mL)0.01< 0.04CK (Creatine Kinase) (U/L)10530–200CK-MB (ng/mL)2.3< 5NT-proBNP (pg/mL)85< 125Serologic Screening for HIV, HBV, HCV, Trypanosoma cruzi (Chagas disease), and SyphilisNegativeNegative Laboratory parameters of the cardiac donor at the time of evaluation Electrocardiography showed sinus rhythm at 82 beats per minute, with no ST-segment abnormalities or conduction disturbances (Fig. 2). Transthoracic echocardiography revealed normal cardiac chamber size and preserved biventricular systolic function, with an estimated left ventricular ejection fraction of 60–65%, without regional wall motion abnormalities or significant valvular disease (Fig. 3). Based on these findings, the heart was accepted for transplantation. Fig. 2Donor electrocardiogram showing normal sinus rhythm at 82 beats per minute, without ST-segment changes or conduction abnormalities Donor electrocardiogram showing normal sinus rhythm at 82 beats per minute, without ST-segment changes or conduction abnormalities Fig. 3Donor transthoracic echocardiography showing normal cardiac chamber sizes and preserved biventricular systolic function (estimated left ventricular ejection fraction 60–65%), without segmental wall motion abnormalities or significant valvular disease Donor transthoracic echocardiography showing normal cardiac chamber sizes and preserved biventricular systolic function (estimated left ventricular ejection fraction 60–65%), without segmental wall motion abnormalities or significant valvular disease Organ procurement was performed via median sternotomy extended to supra- and infraumbilical laparotomy. The heart exhibited preserved biventricular contractility without macroscopic abnormalities of the great vessels (Fig. 4A–B; Video 1). Following aortic cross-clamping, 2000 mL of Custodiol solution at 8 °C was administered as a single dose, and the donor heart was explanted. The organ was preserved in Custodiol solution and transported by air to the recipient center, with an approximate transport time of 40 min. Fig. 4Intraoperative images. (A and B) Donor cardiectomy, showing a heart without gross macroscopic alterations. (C and D) Recipient cardiectomy, demonstrating severe biventricular dilation and marked cardiomegaly (“cor bovinum”), consistent with advanced dilated cardiomyopathy Intraoperative images. (A and B) Donor cardiectomy, showing a heart without gross macroscopic alterations. (C and D) Recipient cardiectomy, demonstrating severe biventricular dilation and marked cardiomegaly (“cor bovinum”), consistent with advanced dilated cardiomyopathy In the recipient, cardiectomy revealed a markedly dilated heart with severely reduced contractility, consistent with cor bovinum (Fig. 4C–D; Video 2). Orthotopic heart transplantation was performed using the bicaval technique. The patient was weaned from cardiopulmonary bypass on the first attempt in a nodal rhythm. Aortic cross-clamp time was 93 min, cardiopulmonary bypass time was 125 min, and total ischemic time was 133 min (Video 3). Postoperatively, the patient was transferred to the intensive care unit under mechanical ventilation with norepinephrine and vasopressin support. Initially, hyperacute rejection was considered in the differential diagnosis given the early and severe clinical presentation. During the postoperative period, an electrocardiogram was performed, with no reported changes suggestive of ischemia in the clinical records; however, a significant elevation in troponin I (80 ng/mL) was observed. A transesophageal echocardiogram demonstrated global biventricular systolic dysfunction (Video 4). He soon developed severe hypotension and bradycardia progressing to asystole, requiring advanced cardiopulmonary resuscitation for 34 min, including three doses of epinephrine. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was initiated via left femoral cannulation, with initial settings of 3615 rpm, flow 5.22 L/min, and FiO₂ 80%. Pharmacologic support included norepinephrine, vasopressin, levosimendan, and isoproterenol. An intra-aortic balloon pump (IABP) was subsequently placed with 1:1 counterpulsation support (Fig. 5), illustrating the patient under full mechanical circulatory assistance. Transthoracic echocardiography showed a dilated right ventricle (45 mm), left ventricular ejection fraction of 25%, and velocity–time integral of 4.9 cm, without pericardial effusion but with bilateral pleural effusion. Arterial blood gas analysis revealed severe metabolic acidosis with a lactate level of 20 mmol/L. Fig. 5Post-heart transplantation patient under full mechanical circulatory support. Venoarterial ECMO via left femoral cannulation and intra-aortic balloon counterpulsation (IABP) at 1:1 support are visible, illustrating the patient with all mechanical support in place Post-heart transplantation patient under full mechanical circulatory support. Venoarterial ECMO via left femoral cannulation and intra-aortic balloon counterpulsation (IABP) at 1:1 support are visible, illustrating the patient with all mechanical support in place Despite maximal hemodynamic and mechanical circulatory support, the patient developed refractory metabolic acidosis, progressive hyperlactatemia, and multiorgan failure, complicated by severe right ventricular dilation, persistent shock, and disseminated intravascular coagulation. He ultimately suffered refractory cardiac arrest and died within the first 24 h after transplantation. Postmortem histopathological examination of the donor heart revealed previously unrecognized severe multivessel atherosclerotic coronary artery disease, with 80% stenosis of the right coronary artery, 75% stenosis of the left coronary artery, and 90% luminal narrowing of the left anterior descending artery. Myocardial tissue showed interstitial inflammatory infiltrate, mild myofibrillar disorganization, focal cardiomyocyte hypereosinophilia, and interstitial edema, without definitive evidence of coagulative necrosis or contraction band necrosis (Fig. 6). Fig. 6Histopathological findings of the donor heart. (A) Right coronary artery showing intimal thickening with significant luminal narrowing of 80%. (B) Left coronary artery with atherosclerotic changes and 75% luminal narrowing. (C) Left anterior descending artery demonstrating intimal thickening and 90% luminal compromise (H&E, ×4). (D–F) Myocardial tissue showing interstitial inflammatory infiltrate, mild myofibrillar disorganization, and focal cardiomyocyte hypereosinophilia, without definitive signs of coagulative necrosis or contraction band necrosis. Overall, findings are compatible with early myocardial injury suggestive of ischemia-reperfusion in the appropriate clinical context Histopathological findings of the donor heart. (A) Right coronary artery showing intimal thickening with significant luminal narrowing of 80%. (B) Left coronary artery with atherosclerotic changes and 75% luminal narrowing. (C) Left anterior descending artery demonstrating intimal thickening and 90% luminal compromise (H&E, ×4). (D–F) Myocardial tissue showing interstitial inflammatory infiltrate, mild myofibrillar disorganization, and focal cardiomyocyte hypereosinophilia, without definitive signs of coagulative necrosis or contraction band necrosis. Overall, findings are compatible with early myocardial injury suggestive of ischemia-reperfusion in the appropriate clinical context Discussion Primary graft dysfunction (PGD) remains the leading cause of early mortality after heart transplantation, with a reported incidence of up to 30% and substantial associated mortality. Although its etiology is multifactorial, donor-related factors may contribute, including the presence of previously unrecognized coronary artery disease [7–9]. Donor heart evaluation continues to represent a major clinical challenge. Current guidelines recommend assessment based on medical history, electrocardiography, and echocardiography, reserving invasive or computed tomography–based coronary imaging for older donors or those with cardiovascular risk factors [10]. However, this approach may be insufficient to detect subclinical coronary artery disease, particularly in younger donors, in whom the likelihood of significant atherosclerosis is often underestimated. Notably, atherosclerotic changes may be present at early ages, even in asymptomatic individuals without traditional risk factors, challenging the assumption that young donor age reliably excludes clinically relevant coronary disease [5, 11, 12]. In the present case, severe multivessel coronary artery disease was identified on postmortem histopathological examination of the donor heart. While these findings demonstrate the presence of advanced structural coronary disease, they do not allow assessment of its functional significance under physiological conditions. Furthermore, postmortem evaluation may not accurately reflect in vivo coronary luminal dimensions or flow dynamics. Therefore, a direct causal relationship between the observed coronary lesions and primary graft dysfunction cannot be definitively established. From a clinical perspective, objective evidence of myocardial ischemia following transplantation was limited. Although a marked elevation in troponin I suggested significant myocardial injury, electrocardiographic data did not demonstrate clear ischemic changes, and no post-transplant coronary imaging was performed. Importantly, coronary angiography was not feasible due to the patient’s profound hemodynamic instability and requirement for full mechanical circulatory support, as transfer to the catheterization laboratory would have posed an unacceptable risk. Therefore, the absence of coronary angiographic data should be interpreted as a consequence of clinical severity rather than a limitation in clinical decision-making. In addition, histopathological findings in the myocardial tissue were consistent with acute myocardial injury but were not specific for ischemia, as similar changes may occur in the context of ischemia–reperfusion injury, prolonged cardiopulmonary resuscitation, severe hemodynamic instability, or other mechanisms involved in PGD. In the transplant setting, donor-transmitted coronary artery disease, although uncommon, has been associated with adverse outcomes, including early graft dysfunction and reduced survival [4, 13]. Nevertheless, given the multifactorial nature of PGD, the relative contribution of donor coronary disease in this case remains uncertain. This report should therefore be interpreted as highlighting a plausible association rather than establishing causality. Importantly, this case underscores both the limitations of conventional donor evaluation and the impact of resource availability on clinical decision-making. In lower-resource settings, where coronary angiography or coronary computed tomography may not be available, donor assessment often relies solely on electrocardiography and echocardiography, which may be insufficient to exclude significant coronary disease—even in young donors [14, 15]. In this context, the selective incorporation of non-invasive coronary imaging in donor evaluation protocols may improve risk stratification. Coronary artery calcium (CAC) scoring by computed tomography has demonstrated high sensitivity for detecting significant coronary disease and a high negative predictive value when the score is zero. However, it is important to acknowledge that CAC scoring does not detect non-calcified plaques and therefore cannot fully exclude clinically relevant coronary artery disease. Consequently, its role in donor assessment should be considered complementary and interpreted within the broader clinical context [16, 17]. Conclusion This case challenges the assumption that young donor age reliably excludes clinically significant coronary artery disease and underscores the need to refine donor screening strategies. It also highlights the limitations of current evaluation approaches, particularly in resource-limited settings where access to advanced diagnostic tools may be restricted, potentially leading to underrecognition of subclinical disease. The selective use of more sensitive diagnostic modalities, including non-invasive coronary imaging when available, may enhance risk stratification and improve transplant safety. However, given the limitations of the present case, a causal relationship cannot be established. Further studies are warranted to better define the role of these strategies, particularly in apparently low-risk young donors. Learning points Primary graft dysfunction may be caused by donor-transmitted coronary artery disease, even in young donors.Standard donor evaluation may not detect subclinical coronary atherosclerosis.Young donor age should not be considered sufficient to exclude significant coronary risk.Conventional diagnostic tools (ECG and echocardiography) may be insufficient for complete coronary assessment.Adjunctive coronary imaging may improve donor selection and transplant outcomes when available. Primary graft dysfunction may be caused by donor-transmitted coronary artery disease, even in young donors. Primary graft dysfunction may be caused by donor-transmitted coronary artery disease, even in young donors. Standard donor evaluation may not detect subclinical coronary atherosclerosis. Standard donor evaluation may not detect subclinical coronary atherosclerosis. Young donor age should not be considered sufficient to exclude significant coronary risk. Young donor age should not be considered sufficient to exclude significant coronary risk. Conventional diagnostic tools (ECG and echocardiography) may be insufficient for complete coronary assessment. Conventional diagnostic tools (ECG and echocardiography) may be insufficient for complete coronary assessment. Adjunctive coronary imaging may improve donor selection and transplant outcomes when available. Adjunctive coronary imaging may improve donor selection and transplant outcomes when available. Supplementary Information Video 1: Donor heart during procurement Video 2: Recipient cardiectomy during transplantation Video 3: Donor heart after implantation Video 4: Postoperative transesophageal echocardiography demonstrating severe biventricular dysfunction Video 1: Donor heart during procurement Video 2: Recipient cardiectomy during transplantation Video 3: Donor heart after implantation Video 4: Postoperative transesophageal echocardiography demonstrating severe biventricular dysfunction